155 related articles for article (PubMed ID: 2183918)
1. Enhanced in vivo sensitivity of vanadyl-treated diabetic rats to insulin.
Ramanadham S; Cros GH; Mongold JJ; Serrano JJ; McNeill JH
Can J Physiol Pharmacol; 1990 Apr; 68(4):486-91. PubMed ID: 2183918
[TBL] [Abstract][Full Text] [Related]
2. In vivo antidiabetic actions of naglivan, an organic vanadyl compound in streptozotocin-induced diabetes.
Cam MC; Cros GH; Serrano JJ; Lazaro R; McNeill JH
Diabetes Res Clin Pract; 1993 May; 20(2):111-21. PubMed ID: 8375263
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.
Yuen VG; Orvig C; McNeill JH
Can J Physiol Pharmacol; 1995 Jan; 73(1):55-64. PubMed ID: 7600453
[TBL] [Abstract][Full Text] [Related]
4. Long-term effectiveness of oral vanadyl sulphate in streptozotocin-diabetic rats.
Cam MC; Pederson RA; Brownsey RW; McNeill JH
Diabetologia; 1993 Mar; 36(3):218-24. PubMed ID: 8462769
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of various vanadium salts on glucose homeostasis in streptozotocin-diabetic rats.
Becker DJ; Ongemba LN; Henquin JC
Eur J Pharmacol; 1994 Aug; 260(2-3):169-75. PubMed ID: 7988641
[TBL] [Abstract][Full Text] [Related]
6. Concentration-dependent glucose-lowering effects of oral vanadyl are maintained following treatment withdrawal in streptozotocin-diabetic rats.
Cam MC; Faun J; McNeill JH
Metabolism; 1995 Mar; 44(3):332-9. PubMed ID: 7885278
[TBL] [Abstract][Full Text] [Related]
7. Oral vanadyl sulfate in treatment of diabetes mellitus in rats.
Ramanadham S; Mongold JJ; Brownsey RW; Cros GH; McNeill JH
Am J Physiol; 1989 Sep; 257(3 Pt 2):H904-11. PubMed ID: 2675634
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of vanadyl treatment on streptozocin-induced diabetes in rats.
Pederson RA; Ramanadham S; Buchan AM; McNeill JH
Diabetes; 1989 Nov; 38(11):1390-5. PubMed ID: 2695373
[TBL] [Abstract][Full Text] [Related]
9. Antidiabetic action of vanadyl in rats independent of in vivo insulin-receptor kinase activity.
Venkatesan N; Avidan A; Davidson MB
Diabetes; 1991 Apr; 40(4):492-8. PubMed ID: 1849104
[TBL] [Abstract][Full Text] [Related]
10. Effects of oral vanadyl treatment on diabetes-induced alterations in the heart GLUT-4 transporter.
Kopp SJ; Daar J; Paulson DJ; Romano FD; Laddaga R
J Mol Cell Cardiol; 1997 Sep; 29(9):2355-62. PubMed ID: 9299359
[TBL] [Abstract][Full Text] [Related]
11. Improvement of glucose homeostasis by oral vanadyl or vanadate treatment in diabetic rats is accompanied by negative side effects.
Domingo JL; Gómez M; Llobet JM; Corbella J; Keen CL
Pharmacol Toxicol; 1991 Apr; 68(4):249-53. PubMed ID: 1866388
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like effect of vanadyl ion on streptozotocin-induced diabetic rats.
Sakurai H; Tsuchiya K; Nukatsuka M; Sofue M; Kawada J
J Endocrinol; 1990 Sep; 126(3):451-9. PubMed ID: 2170556
[TBL] [Abstract][Full Text] [Related]
13. Administration of vanadyl sulfate by gavage does not normalize blood glucose levels in streptozotocin-induced diabetic rats.
Domingo JL; Sanchez DJ; Gomez M; Llobet JM; Corbella J
Res Commun Chem Pathol Pharmacol; 1992 Mar; 75(3):369-72. PubMed ID: 1509205
[TBL] [Abstract][Full Text] [Related]
14. Improvement of impaired glucose tolerance by oral administration of vanadyl sulfate by gavage in streptozotocin-induced diabetic rats.
Tsunajima T; Tatsuki R; Satoh K; Yamamoto A; Hoshi K; Ichihara K
Res Commun Mol Pathol Pharmacol; 1997 Nov; 98(2):190-200. PubMed ID: 9467827
[TBL] [Abstract][Full Text] [Related]
15. The effect of vanadyl treatment on vascular responsiveness of streptozotocin-diabetic rats.
Ozçelikay AT; Pekiner C; Ari N; Oztürk Y; Ozüari A; Altan VM
Diabetologia; 1994 Jun; 37(6):572-8. PubMed ID: 7926341
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of vanadyl sulfate on the pancreas of streptozotocin-induced diabetic rats.
Bolkent S; Bolkent S; Yanardag R; Tunali S
Diabetes Res Clin Pract; 2005 Nov; 70(2):103-9. PubMed ID: 16188572
[TBL] [Abstract][Full Text] [Related]
17. Oral vanadate and Tiron in treatment of diabetes mellitus in rats: improvement of glucose homeostasis and negative side-effects.
Domingo JL; Sanchez DJ; Gomez M; Llobet JM; Corbella J
Vet Hum Toxicol; 1993 Dec; 35(6):495-500. PubMed ID: 8303815
[TBL] [Abstract][Full Text] [Related]
18. Distinct glucose lowering and beta cell protective effects of vanadium and food restriction in streptozotocin-diabetes.
Cam MC; Rodrigues B; McNeill JH
Eur J Endocrinol; 1999 Nov; 141(5):546-54. PubMed ID: 10576774
[TBL] [Abstract][Full Text] [Related]
19. The effects of vanadium treatment on bone in diabetic and non-diabetic rats.
Facchini DM; Yuen VG; Battell ML; McNeill JH; Grynpas MD
Bone; 2006 Mar; 38(3):368-77. PubMed ID: 16256449
[TBL] [Abstract][Full Text] [Related]
20. One-year treatment of streptozotocin-induced diabetic rats with vanadyl sulphate.
Dai S; Thompson KH; McNeill JH
Pharmacol Toxicol; 1994 Feb; 74(2):101-9. PubMed ID: 8190697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
